No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr3:98398000-98398200 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
2 |
chr3:98399400-98399800 |
Enhancers |
NHEK |
skin
|
3 |
chr3:98400400-98400600 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
4 |
chr3:98400400-98401000 |
Enhancers |
Gastric |
stomach
|
5 |
chr3:98400400-98401600 |
Enhancers |
Stomach Mucosa |
stomach
|
6 |
chr3:98400400-98401800 |
Enhancers |
HepG2 |
liver
|
7 |
chr3:98409400-98409600 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
8 |
chr3:98409400-98410000 |
Enhancers |
Placenta |
Placenta
|
9 |
chr3:98409400-98410200 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
10 |
chr3:98409600-98409800 |
Enhancers |
Stomach Mucosa |
stomach
|
11 |
chr3:98409600-98410000 |
Flanking Active TSS |
Muscle Satellite Cultured Cells |
--
|
12 |
chr3:98409600-98410000 |
Enhancers |
NH-A |
brain
|
13 |
chr3:98409600-98410200 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
14 |
chr3:98409600-98410200 |
Enhancers |
Osteobl |
bone
|
15 |
chr3:98409600-98411600 |
Enhancers |
HepG2 |
liver
|
16 |
chr3:98409600-98416000 |
Enhancers |
HUVEC |
blood vessel
|
17 |
chr3:98409800-98410000 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
18 |
chr3:98409800-98410200 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
19 |
chr3:98409800-98411000 |
Weak transcription |
Stomach Mucosa |
stomach
|
20 |
chr3:98409800-98412200 |
Enhancers |
Fetal Heart |
heart
|
21 |
chr3:98410000-98411200 |
Weak transcription |
Placenta |
Placenta
|
22 |
chr3:98410000-98411400 |
Weak transcription |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
23 |
chr3:98410000-98412400 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
24 |
chr3:98410200-98414400 |
Weak transcription |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
25 |
chr3:98410200-98414400 |
Weak transcription |
Osteobl |
bone
|
26 |
chr3:98410200-98417600 |
Weak transcription |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
27 |
chr3:98411000-98412400 |
Enhancers |
Stomach Mucosa |
stomach
|
28 |
chr3:98411200-98412400 |
Enhancers |
Placenta |
Placenta
|
29 |
chr3:98411200-98412800 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
30 |
chr3:98411400-98412200 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
31 |
chr3:98411400-98412200 |
Enhancers |
Liver |
Liver
|
32 |
chr3:98411600-98411800 |
Flanking Active TSS |
HepG2 |
liver
|
33 |
chr3:98411800-98412200 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
34 |
chr3:98411800-98412200 |
Flanking Bivalent TSS/Enh |
HepG2 |
liver
|
35 |
chr3:98411800-98412600 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
36 |
chr3:98412000-98412200 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
37 |
chr3:98412200-98414200 |
Weak transcription |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
38 |
chr3:98412200-98420200 |
Weak transcription |
Primary hematopoietic stem cells short term culture |
blood
|
39 |
chr3:98412400-98414200 |
Weak transcription |
Muscle Satellite Cultured Cells |
--
|
40 |
chr3:98414200-98415400 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
41 |
chr3:98414200-98418600 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
42 |
chr3:98414400-98414800 |
Enhancers |
Osteobl |
bone
|
43 |
chr3:98414400-98415400 |
Enhancers |
NHEK |
skin
|
44 |
chr3:98414400-98416600 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
45 |
chr3:98414600-98415400 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
46 |
chr3:98414800-98415000 |
Flanking Active TSS |
Osteobl |
bone
|
47 |
chr3:98414800-98416000 |
Enhancers |
HMEC |
breast
|
48 |
chr3:98415000-98415200 |
Enhancers |
Osteobl |
bone
|
49 |
chr3:98415000-98415800 |
Enhancers |
NHLF |
lung
|
50 |
chr3:98415200-98415400 |
Flanking Active TSS |
Osteobl |
bone
|